本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 株洲欧科亿数控精密刀具股份有限公司（以下简称"公司"）于 2023 年 9 月 8 日召开第二届董事会第三十四次会议，审议通过了《关于修改<公司章程> 并办理工商变更登记的议案》，该议案尚需要提交公司 2023 年第一次临时股东 大会审议，具体情况公告如下： 一、董事人数调整情况 根据公司实际情况，为进一步完善公司治理结构，提高董事会运作效率，公 司对董事会成员人数进行调整，将董事会成员人数由 9 名调整为 5 名。其中，非 独立董事由 6 人调整为 3 人，独立董事人数由 3 名调整为 2 名。 证券代码：688308 证券简称：欧科亿 公告编号：2023-038 株洲欧科亿数控精密刀具股份有限公司 关于修改《公司章程》并办理工商变更登的公告 特此公告 株洲欧科亿数控精密刀具股份有限公司董事会 2023 年 9 月 9 日 | 修改前 | | | | 修改后 | | | | | --- | --- | --- | --- | --- | --- | --- | --- | ...

证券代码：688308 证券简称：欧科亿 公告编号：2023-040 株洲欧科亿数控精密刀具股份有限公司 关于召开 2023 年第一次临时股东大会的通知 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 一、召开会议的基本情况 （一）股东大会类型和届次 2023 年第一次临时股东大会 （二）股东大会召集人：董事会 （三）投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相 结合的方式 （四）现场会议召开的日期、时间和地点 召开日期时间：2023 年 9 月 27 日 14 点 00 分 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东大会召开当日的交易时间段，即 9:15-9:25,9:30-11:30，13:00-15:00；通过 互联网投票平台的投票时间为股东大会召开当日的 9:15-15:00。 （六）融资融券、转融通、约定购回业务账户和沪股通投资者的投票程序 股东大会召开日期：2023年9月27日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 涉及融 ...

民生证券股份有限公司 关于株洲欧科亿数控精密刀具股份有限公司 2023 年上半年持续督导跟踪报告 民生证券股份有限公司（以下简称"民生证券""保荐机构"）作为株洲欧科亿 数控精密刀具股份有限公司（以下简称"欧科亿""公司"）首次公开发行股票并在 科创板上市及 2022 年度向特定对象发行 A 股股票的保荐机构，根据《证券发行 上市保荐业务管理办法》及《上海证券交易所科创板股票上市规则》等有关法律 法规和规范性文件的要求，对欧科亿进行持续督导，持续督导期为 2020 年 12 月 10 日至 2024 年 12 月 31 日。民生证券通过日常沟通、定期回访、现场检查、 尽职调查等方式进行持续督导，现就 2023 年 1-6 月持续督导工作报告如下： 1 序号 工作内容 实施情况 1 建立健全并有效执行持续督导工作制度，并针 对具体的持续督导工作制定相应的工作计划。 保荐机构已建立健全并有效执行了持 续督导制度，并制定了相应的工作计 划。 2 根据中国证监会相关规定，在持续督导工作开 始前，与上市公司签署持续督导协议，明确双 方在持续督导期间的权利义务，并报上海证券 交易所备案。 保荐机构已与欧科亿签订承销及保荐 ...

证券代码：688308 证券简称：欧科亿 公告编号：2023-032 株洲欧科亿数控精密刀具股份有限公司 关于收到公司董事长提议回购公司股份的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 株洲欧科亿数控精密刀具股份有限公司（以下简称"公司"）董事会于 2023 年 8 月 29 日收到公司董事长袁美和先生提交的《关于提议株洲欧科亿数控精密 刀具股份有限公司回购公司股份的函》，具体内容如下： 一、提议回购股份的原因和目的 7、回购股份的资金来源：公司自有资金； 袁美和先生基于对公司未来发展的信心和对公司价值的认可，为充分激发公 司员工积极性，持续建立公司长效激励机制，并增强投资者对公司的投资信心， 紧密结合公司利益、股东利益与员工利益，促进公司健康可持续发展，根据相关 法律法规，提议公司以集中竞价交易方式回购部分公司股份，并将全部用于公司 股权激励或员工持股计划。 二、提议内容 1、回购股份的种类：公司发行的人民币普通股（A 股）； 2、回购股份的用途：用于股权激励或员工持股计划。若公司未能在股份回 购实施结果 ...

Financial Performance - The company reported a significant increase in revenue for the first half of 2023, achieving a total of 500 million yuan, representing a growth of 25% year-over-year[16]. - The company's operating revenue for the first half of 2023 was ¥532,720,325.41, a 1.34% increase compared to ¥525,699,317.54 in the same period last year[21]. - The net profit attributable to shareholders decreased by 5.72% to ¥108,432,031.46 from ¥115,005,247.56 year-on-year[21]. - The net cash flow from operating activities was negative at -¥44,011,236.74, a significant decline of 147.37% compared to ¥92,905,180.14 in the previous year[21]. - Basic earnings per share fell by 15.85% to ¥0.69 from ¥0.82 in the same period last year[22]. - The company's total assets increased by 10.68% to ¥3,511,226,073.73 from ¥3,172,547,291.83 at the end of the previous year[21]. - The net assets attributable to shareholders increased by 2.33% to ¥2,524,954,207.09 from ¥2,467,547,203.59 at the end of the previous year[21]. - Operating costs rose to CNY 358,764,011.97, reflecting a 7.63% increase from CNY 333,329,062.57, primarily due to higher depreciation expenses[84]. - The company reported a gross profit margin of approximately 20.0% for the first half of 2023, compared to 23.5% in the same period last year[183]. Research and Development - Research and development expenses have increased by 30% to support innovation and new technology initiatives[16]. - The company received 8 domestic authorized patents during the reporting period, including 1 invention patent, and filed 3 new patent applications, bringing the total to 123 authorized patents[49]. - Total R&D investment amounted to ¥24,491,441.90, a decrease of 22.11% compared to ¥31,442,712.69 in the same period last year[52]. - The company is focusing on R&D innovations in basic material technologies and expanding its product line to offer comprehensive cutting solutions[47]. - The company has developed a new TiCN ceramic cutting tool material with a TRS of ≥2100 MPa and K1c of ≥9.0, suitable for high-temperature processing fields[15]. - The company has developed a new high-hardness mold steel milling material, achieving a TRS of over 3500 and KIC of 7.0, targeting difficult-to-machine high-hardness materials[16]. Market Strategy and Expansion - The company has set a revenue target of 1 billion yuan for the full year 2023, indicating an optimistic outlook for the second half of the year[16]. - The company plans to expand its market presence in Southeast Asia, targeting a 10% market share by the end of 2024[16]. - A new strategic partnership has been established with a leading machinery manufacturer to enhance distribution channels[16]. - The company is actively exploring export markets as domestic tool manufacturers enhance their capabilities and reduce reliance on imports, aligning with national strategies like "Made in China 2025"[44]. - The company has established over 40 overseas channel layouts, primarily in automotive, mold manufacturing, aerospace, and rail transit sectors[74]. Risks and Challenges - The company has identified potential risks related to raw material price fluctuations, which could impact profit margins[16]. - The company faces risks from intensified market competition, particularly from imported brands that dominate the domestic CNC tool market[77]. - The company has faced risks related to the management of accounts receivable and potential defaults from downstream customers and banks[81]. - The company's main raw materials, tungsten carbide and cobalt powder, account for approximately 80% of the cost of hard alloy products, making it vulnerable to price fluctuations[80]. Environmental and Social Responsibility - The company has invested ¥272,800 in environmental protection during the reporting period[104]. - The company has established an environmental protection mechanism to ensure compliance with regulations[104]. - The company has created over 400 job opportunities in the local area, contributing nearly 100 million yuan in taxes, and supporting local poverty alleviation efforts[111]. - The company has implemented measures to reduce carbon emissions, including optimizing production processes and using off-peak electricity to lower energy consumption[110]. - The company has established emergency response plans for environmental incidents, which have been filed with local environmental authorities[109]. Shareholder and Corporate Governance - The company completed the issuance of 675,200 restricted stock units as part of its incentive plan, which are now listed and tradable[101]. - The company has committed to a three-year shareholder dividend return plan, adhering to the profit distribution policy outlined in its articles of association[118]. - The company guarantees that its public offering of shares and listing on the Sci-Tech Innovation Board does not involve any fraudulent issuance[119]. - The company will ensure timely and accurate disclosure of any shareholding changes as per regulatory requirements[115]. - The company has established a framework for accountability among its directors and senior management regarding the fulfillment of public commitments[125].

株洲欧科亿数控精密刀具股份有限公司 独立董事关于公司第二届董事会第三十三次会议 相关事项的独立意见 根据《公司法》《上海证券交易所科创板股票上市规则》等法律法规和规范 性文件以及《株洲欧科亿数控精密刀具股份有限公司章程》等相关规定，作为株 洲欧科亿数控精密刀具股份有限公司（以下简称"公司"）的独立董事，本着认 真、负责的态度，基于独立、审慎、客观的原则，我们认真审阅了本次会议的相 关资料，现针对公司第二届董事会第三十三次会议相关事项发表独立意见如下： 一、关于 2023 年半年度募集资金存放与实际使用情况的专项报告 公司 2023 年半年度募集资金存放与使用情况符合《上海证券交易所科创板 股票上市规则》《上市公司监管指引第 2 号——上市公司募集资金管理和使用的 监管要求》《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》 等法律法规、规范性文件的相关规定，符合公司《募集资金管理制度》的规定， 对募集资金进行了专户存储和专项使用，并及时履行了相关信息披露义务，募集 资金具体使用情况与公司已披露情况一致，不存在变相改变募集资金用途和损害 股东利益的情况，不存在违规使用募集资金的情况。因此，我们同 ...

证券代码：688308 证券简称：欧科亿 公告编号：2023-030 株洲欧科亿数控精密刀具股份有限公司 第二届监事会第二十九次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 株洲欧科亿数控精密刀具股份有限公司（以下简称"公司"）第二届监事会 第二十九次会议于 2023 年 8 月 24 日在公司会议室以现场和通讯表决方式召开， 会议通知已于 2023 年 8 月 14 日以电话或传真的方式发出。会议应出席监事 3 人，实际出席监事 3 人，会议由监事会主席张奕先生主持。本次会议的召集和召 开符合《中华人民共和国公司法》等法律、法规、规范性文件和《公司章程》的 有关规定。 二、监事会会议审议情况 公司 2023 年半年度报告及其摘要内容真实、准确、完整，无虚假记载、误 导性陈述或者重大遗漏，其编制、审核以及董事会的审议程序符合法律法规、公 司章程等相关规定，内容与格式符合相关规定，公允地反映了公司 2023 年半年 度的财务状况和经营成果等事项；报告编制过程中，未发现公司参与半年度报告 ...

证券代码：688308 证券简称：欧科亿 公告编号：2023-031 株洲欧科亿数控精密刀具股份有限公司 2023 年半年度募集资金存放与实际使用情况的专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 根据中国证券监督管理委员会《上市公司监管指引第 2 号——上市公司募集 资金管理和使用的监管要求（2022 年修订）》（证监会公告〔2022〕15 号）、《上海 证券交易所科创板上市公司自律监管指引第 1 号——规范运作》及《上海证券交 易所上市公司自律监管指南第 1 号——公告格式》等有关规定，株洲欧科亿数控 精密刀具股份有限公司（以下简称"公司"）董事会编制了 2023 年半年度募集资 金存放与实际使用情况的专项报告，具体如下： 一、募集资金基本情况 （一）募集资金到位情况 1.首次公开发行股票募集资金金额、资金到位情况 根据中国证券监督管理委员会证监许可[2020]2980 号文《关于同意株洲欧科 亿数控精密刀具股份有限公司首次公开发行股票注册的批复》核准，本公司向社 会公开发行 2,500 万股人民币普通股 ...

证券代码：688308 证券简称：欧科亿 公告编号：2023-020 株洲欧科亿数控精密刀具股份有限公司 关于参加 2022 年度先进金属材料专场集体业绩说明 会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： （ http://roadshow.sseinfo.com/） 投资者可于 2023 年 5 月 23 日(星期二) 16:00 前通过邮件、电话、传真 等形式将需要了解和关注的问题提前提供给公司。公司将在文字互动环节对投资 者普遍关注的问题进行回答。 株洲欧科亿数控精密刀具股份有限公司（以下简称"公司"）已于 2023 年 4 月 12 日发布公司 2022 年年度报告，为便于广大投资者更全面深入地了解公 司 2022 年度经营成果、财务状况、发展理念，公司参与了由上海证券交易所 主办的 2022 年度先进金属材料专场集体业绩说明会，此次活动将采用视频和 网络文字互动的方式举行，投资者可登录上海证券交易所上证路演中心 （http://roadshow.sseinfo.com/）参与线上互动交 ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥283,832,837.38, representing an increase of 8.38% compared to the same period last year[3] - The net profit attributable to shareholders was ¥59,295,431.26, reflecting a growth of 4.78% year-on-year[3] - The net profit attributable to shareholders after deducting non-recurring gains and losses decreased by 8.87% to ¥48,506,564.31[3] - Basic and diluted earnings per share were both ¥0.53, down by 6.96% compared to the previous year[3] - Total operating revenue for Q1 2023 was CNY 283,832,837.38, an increase of 8.1% compared to CNY 261,896,824.78 in Q1 2022[14] - Net profit for Q1 2023 reached CNY 59,295,431.26, compared to CNY 56,588,953.49 in Q1 2022, representing a growth of 4.8%[17] - Earnings per share for Q1 2023 were CNY 0.53, a decrease from CNY 0.57 in Q1 2022[18] Cash Flow and Liquidity - The net cash flow from operating activities was negative at -¥58,321,503.23, indicating a significant cash outflow[3] - Cash flow from operating activities in Q1 2023 was CNY 95,711,902.55, down from CNY 137,831,810.91 in Q1 2022, indicating a decline of 30.5%[20] - In Q1 2023, the net cash flow from operating activities was -$58,321,503.23, compared to -$4,575,429.99 in Q1 2022, indicating a significant decline in operational cash flow[21] - The total cash outflow from investing activities was $189,746,382.70, while cash inflow was $62,223,691.10, resulting in a net cash flow from investing activities of -$127,522,691.60, a decrease from $8,384,231.51 in the previous year[21] - Cash inflow from financing activities amounted to $200,000,000.00, a substantial increase from $40,000,000.00 in Q1 2022, while net cash flow from financing activities was $198,798,109.71, up from $38,636,472.22[22] - The company's cash and cash equivalents increased by $12,881,921.77 in Q1 2023, compared to an increase of $42,215,241.10 in Q1 2022[22] - The ending balance of cash and cash equivalents was $450,578,664.32, up from $216,102,120.95 in the same quarter last year[22] Assets and Liabilities - Total assets at the end of the reporting period were ¥3,400,875,428.11, an increase of 7.20% from the end of the previous year[4] - Total current assets as of March 31, 2023, amounted to CNY 2,088,098,304.67, an increase from CNY 1,906,292,683.75 at the end of 2022, reflecting a growth of approximately 9.5%[11] - Total liabilities as of Q1 2023 amounted to CNY 872,183,096.14, an increase from CNY 705,000,088.24 in the previous year[14] - The company’s total liabilities increased significantly, reflecting ongoing investments and operational costs, although specific figures were not disclosed in the report[21] Research and Development - The total R&D investment amounted to ¥11,275,382.51, which is a decrease of 20.19% year-on-year[3] - The ratio of R&D investment to operating revenue was 3.97%, down by 1.42 percentage points from the previous year[4] - Research and development expenses for Q1 2023 were CNY 11,275,382.51, down from CNY 14,127,745.27 in Q1 2022, a decrease of 20.1%[14] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 4,370[8] - The company reported a total of 10,676,500 shares held by the largest shareholder, indicating significant ownership concentration[10] - Total equity attributable to shareholders was CNY 2,528,692,331.97 in Q1 2023, compared to CNY 2,467,547,203.59 in Q1 2022, marking an increase of 2.9%[14] Strategic Initiatives - The company has engaged in strategic partnerships, enhancing its market position and expanding its investment portfolio[10] - The company plans to focus on new product development and market expansion strategies in the upcoming quarters[10] Operational Costs - Total operating costs for Q1 2023 were CNY 219,124,826.64, up from CNY 195,261,086.71 in Q1 2022, reflecting an increase of 12.2%[14] - The company reported a total cash outflow from operating activities of $154,033,405.78, compared to $142,407,240.90 in Q1 2022, reflecting increased operational expenses[21] - The company paid $34,415,948.55 to employees in Q1 2023, down from $47,795,350.75 in Q1 2022, indicating a reduction in payroll expenses[21] - Tax payments increased to $12,365,419.83 in Q1 2023 from $8,310,247.43 in Q1 2022, showing a rise in tax liabilities[21] - The company received $62,000,000.00 from investment recoveries, a decrease from $315,000,000.00 in the previous year, indicating a decline in investment returns[21]